Tumor rim cells: From resistance to vascular targeting agents to complete tumor ablation

Khaled Seidi, Rana Jahanban-Esfahlan, Nosratollah Zarghami

Open source

DOI
10.1177/1010428317691001
Published
2017-03
Container
Tumor Biology
Publisher
SAGE Publications
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1177/1010428317691001,
  title = {Tumor rim cells: From resistance to vascular targeting agents to complete tumor ablation},
  author = {Khaled Seidi and Rana Jahanban-Esfahlan and Nosratollah Zarghami},
  year = {2017},
  journal = {Tumor Biology},
  doi = {10.1177/1010428317691001},
  url = {https://doi.org/10.1177/1010428317691001}
}

RIS

TY  - JOUR
TI  - Tumor rim cells: From resistance to vascular targeting agents to complete tumor ablation
AU  - Khaled Seidi
AU  - Rana Jahanban-Esfahlan
AU  - Nosratollah Zarghami
PY  - 2017
JO  - Tumor Biology
DO  - 10.1177/1010428317691001
UR  - https://doi.org/10.1177/1010428317691001
ER  - 

APA

Seidi, K., Jahanban-Esfahlan, R., & Zarghami, N. (2017). Tumor rim cells: From resistance to vascular targeting agents to complete tumor ablation. Tumor Biology. https://doi.org/10.1177/1010428317691001

Source records